XPeng downgraded to Sell at UBS following greater than 50% advance

As previously reported, UBS analyst Paul Gong downgraded XPeng (XPEV) to Sell from Neutral with a price target of $8.80, up from $8.20. The share price has risen over 50% since September as the newly launched MONA MO3 and P7+ reported higher-than-expected early orders and deliveries, notes the analyst, who argues that new launch momentum and EREV potential are now “overly priced in.”

Don't Miss our Black Friday Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on XPEV:

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.